메뉴 건너뛰기




Volumn 4, Issue 1, 2015, Pages 27-31

The necessity of having a tetradentate ligand to extract Copper(II) ions from amyloids

Author keywords

Alzheimers disease; chelating agents; copper homeostasis; medicinal chemistry; therapeutic agents

Indexed keywords

CHELATION; CONTROLLED DRUG DELIVERY; COPPER COMPOUNDS; DRUG PRODUCTS; GLYCOPROTEINS; LIGANDS; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES; PROTEINS; REDOX REACTIONS; TARGETED DRUG DELIVERY;

EID: 84923293193     PISSN: None     EISSN: 21911363     Source Type: Journal    
DOI: 10.1002/open.201402075     Document Type: Article
Times cited : (20)

References (22)
  • 11
    • 84895836147 scopus 로고    scopus 로고
    • Angew. Chem. 2013, 125, 11316-11319.
    • (2013) Angew. Chem. , vol.125 , pp. 11316-11319
  • 18
    • 78751559713 scopus 로고    scopus 로고
    • Angew. Chem. 2009, 121, 9437-9440.
    • (2009) Angew. Chem. , vol.121 , pp. 9437-9440


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.